Shortage of children's cancer drug should ease, according to FDA
Feb 17, 2012
While there is currently a shortage of a children's cancer drug, Food and Drug Administration officials said the situation should ease soon.
Valerie Jensen, associate director of the FDA, told The Associated Press that her team is working with the makers of preservative-free methotrexate. This drug is used to treat the most common childhood cancer, acute lymphoblastic leukemia.
“We understand from all three companies that they will be starting to ship by the end of the month,” Jensen told the AP, adding that not much can be further discussed due to proprietary information.
Hospitals have warned the FDA that treatment of children with this disease could stall if new drugs aren't shipped out within a couple weeks, which could lessen the survival chances of these kids.
The Digital Journal said Methotrexate is used for chemotherapy either alone or with other drugs. It can treat children's cancer and breast, head, neck and other forms of the disease.